Recent reports have indicated that the National Medical Products Administration has addressed the potential carcinogenicity associated with CAR-T cell immunotherapy.
Many previous studies have shown that statins are able to have an impact on cancer cells but the results have yet to be seen in human trials. Keele University has now conducted research that could point towards why they have proved ineffective so far.